The UCSF Brain Tumor SPORE Biospecimen/Pathology Core provides staff and technology dedicated to the procurement, processing, storing, distribution, and histopathologic analysis of high-quality brain tumor biospecimens for translational science research. Our mission is to enhance biospecimen quality and utility through use of optimized standard operating procedures, multi-modality preservation, integrated histopathologic and molecular annotation, and a computerized inventory, request and tracking system. All aspects of this Core are performed in accordance with the guiding principles set forth in the 2016 National Cancer Institute Best Practice for Biorepository Guidelines. In order to maximize sharing and integration of SPORE projects, the Biospecimen Core collects and makes available data derived from all distributed brain tumor biospecimens.
Specific Aims of SPORE Biospecimen/Pathology Core: 1. To procure brain tumor patient biospecimens from the operating room and from animal models used by the Projects with optimized handling to maximize cell viability and/or minimize the cold-ischemia time so as to meet the tissue accrual requirements for all of the proposed Brain Tumor SPORE projects and clinical trials. 2. To perform quality control assays on archived biospecimens collected from the operating room and animal models, to ensure availability of adequate numbers of consistently handled specimens that will yield high- quality data for SPORE projects and clinical trials. High quality biospecimens are critical for all proposed SPORE projects. 3. To provide standardized routine and advanced tissue handling/processing and analytical techniques, including immunohistochemistry, fluorescence in situ hybridization, tissue microarray construction, DNA/RNA extraction, protein isolation, and preparation of viable cells that will allow each SPORE project to fulfill its goals. 4. To maintain a SPORE Biospecimen/Pathology Core database containing demographic data, integrated histopathologic and molecular annotation, results from molecular analyses, and tissue distributions (internal and external) that will be linked to relational clinical databases maintained by the SPORE Biostatistics and Clinical Core and used by all SPORE Projects.

Public Health Relevance

The UCSF Brain Tumor SPORE Biospecimen/Pathology Core provides staff and technology dedicated to the procurement, processing, storing, distribution, and analysis of high-quality brain tumor biospecimens. This includes maximizing biospecimen use and data sharing to accelerate advances in translational brain tumor research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA097257-16
Application #
9568987
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
16
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Hayes, Josie; Yu, Yao; Jalbert, Llewellyn E et al. (2018) Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol 20:632-641
Ostrom, Quinn T; Kinnersley, Ben; Armstrong, Georgina et al. (2018) Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age. Int J Cancer 143:2359-2366
Pekmezci, Melike; Stevers, Meredith; Phillips, Joanna J et al. (2018) Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol 135:485-488
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Taylor, Jennie W; Parikh, Mili; Phillips, Joanna J et al. (2018) Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. J Neurooncol 140:477-483
Luks, Tracy L; McKnight, Tracy Richmond; Jalbert, Llewellyn E et al. (2018) Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas. Transl Oncol 11:941-949
Viswanath, Pavithra; Radoul, Marina; Izquierdo-Garcia, Jose Luis et al. (2018) 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Res 78:2290-2304
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794
Mancini, Andrew; Xavier-Magalhães, Ana; Woods, Wendy S et al. (2018) Disruption of the ?1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. Cancer Cell 34:513-528.e8
Disney-Hogg, Linden; Sud, Amit; Law, Philip J et al. (2018) Influence of obesity-related risk factors in the aetiology of glioma. Br J Cancer 118:1020-1027

Showing the most recent 10 out of 362 publications